Clinical Trial of Uterine Artery Embolization for Uterine Leiomyoma

Status Enrolling by invitation

Clinical Trial Summary

The efficacy and safety of uterine artery embolization, as compared with standard surgical methods, for the treatment of symptomatic uterine fibroids remain uncertain. The purpose of this trial is to evaluate the uterine volume and tumor size reduction, symptomatic relief, complication, fertility, ovarian function and quality of life with uterine artery embolization for uterine fibroids comparing with standard surgical methods.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Related Conditions & MeSH terms

Leiomyoma

Clinical Trial Details

NCT number	NCT00821275
Study type	Interventional
Source	Sun Yat-sen University
Contact
Status	Enrolling by invitation
Phase	Phase 2/Phase 3
Start date	January 2008
Completion date	December 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04172272` - The Influence of TAP Block in the Control of Postoperative Pain After Laparotomy for Gynecological Procedures	N/A
Terminated	`NCT02940041` - Concordance Between Sonography Amd MRI for Presurgical Diagnosis of Uterine Mesenchymal Malignant Tumors
Withdrawn	`NCT00768742` - Safety and Effectiveness Study of RF Ablation of Uterine Fibroids to Reduce Menstrual Bleeding: the Fibroid Ablation Study	N/A
Completed	`NCT00152256` - A Study to Evaluate of the Safety and Effectiveness of Asoprisnil in Treating Women With Uterine Fibroids	Phase 3
Completed	`NCT00156195` - Study to Evaluate the Safety of Asoprisnil in the Treatment of Uterine Fibroids	Phase 3
Completed	`NCT00160381` - A Study to Evaluate the Safety and Effectiveness of Asoprisnil in the Treatment of Uterine Fibroids	Phase 3
Recruiting	`NCT04214457` - Development of a Predictive Model for Early Differential Diagnosis of Uterine Leiomyomas and Leiomyosarcomas
Completed	`NCT00044876` - Treatment of Uterine Fibroids With CDB-2914, an Experimental Selective Progesterone Receptor Antagonist	Phase 2
Completed	`NCT02889848` - Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids)	Phase 1
Recruiting	`NCT04145518` - Mechanistic Characterization of Uterine Pain	Phase 4
Completed	`NCT01816815` - Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670	Phase 1
Completed	`NCT00891657` - Post Market Study for an Adhesion Barrier Following Laparoscopic Myomectomy	N/A
Completed	`NCT00156156` - Study of Asoprisnil in the Treatment of Uterine Fibroids.	Phase 3
Recruiting	`NCT05538689` - Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL)	Phase 4
Active, not recruiting	`NCT03323905` - Single Arm Study Using the Symphony -- MRI Guided Focused Ultrasound System for the Treatment of Leiomyomas	N/A
Terminated	`NCT03342859` - Mode of Action Study of Vilaprisan and Ulipristal Acetate in Patients With Uterine Fibroids for Whom Surgery is Planned	Phase 1
Recruiting	`NCT06135870` - Role of Senescent Cells in Uterine Fibroid Pathogenesis (SOUL Study)
Completed	`NCT02777203` - Power Morcellation Systems for Laparoscopic Hysterectomy and Myomectomy	N/A
Completed	`NCT02189083` - Study of Tumor-shrinking Decoction (TSD) to Treat Symptomatic Uterine Fibroids	Phase 3
Completed	`NCT01123603` - Lower Urinary Tract Infection (UTI) Evaluation in Women With Uterine Leiomyomata	N/A